Status: Phase 3
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Deafness; Hearing Loss; Hearing Loss, Noise-Induced Phase 3 ClinicalTrials
CONTENTS